Vitamin D dosing is more nuanced than most micronutrients because optimal intake depends on baseline serum levels, body composition, sun exposure, and skin pigmentation. This guide covers clinically supported dosing ranges, measurement conversions, co-factor pairings, and monitoring targets.
What Dose Should Most Adults Take Daily?
The Institute of Medicine (IOM) set the Recommended Dietary Allowance at 600 IU (15 mcg) for adults aged 1–70 and 800 IU (20 mcg) for adults over 70, based on the goal of maintaining serum 25(OH)D above 20 ng/mL (Ross et al., 2011). The Endocrine Society recommends a higher target of ≥30 ng/mL and suggests that most adults may need 1,500–2,000 IU daily to consistently reach that threshold. The IOM’s 600 IU recommendation assumes some contribution from sun exposure, which many indoor-focused adults do not receive. Population pharmacokinetic modeling shows that 1,000 IU daily raises serum 25(OH)D by approximately 10 ng/mL in most adults — meaning someone starting at 20 ng/mL would reach 30 ng/mL on 1,000 IU. Individuals with obesity may need 2–3 times the standard dose because vitamin D is sequestered in adipose tissue, reducing bioavailability in proportion to body fat percentage. A practical starting range of 1,000–2,000 IU daily covers most adults without known deficiency and carries no risk of toxicity, as the IOM’s Tolerable Upper Intake Level is 4,000 IU daily for adults.
How Are IU and Micrograms Related?
The conversion between International Units (IU) and micrograms (mcg) for vitamin D is fixed at 1 mcg = 40 IU. This means:
| IU | mcg |
|---|---|
| 400 IU | 10 mcg |
| 1,000 IU | 25 mcg |
| 2,000 IU | 50 mcg |
| 4,000 IU | 100 mcg |
| 10,000 IU | 250 mcg |
Supplement labels in the US typically display both units. European supplements more commonly use micrograms. The IU system was established based on biological activity measurements in the 1930s and persists in vitamin D labeling by convention. When comparing products or interpreting research papers, verify which unit is being used — a “50 mcg” supplement and a “2,000 IU” supplement deliver identical amounts of vitamin D.
What Protocol Corrects Existing Deficiency?
Deficiency correction protocols use higher short-term doses to restore serum 25(OH)D to adequate levels before transitioning to maintenance dosing. The Endocrine Society recommends 50,000 IU weekly for 8 weeks (equivalent to approximately 7,000 IU daily) for adults with serum 25(OH)D below 20 ng/mL, followed by a maintenance dose of 1,500–2,000 IU daily. A 2023 study of 160 patients with vitamin D deficiency found that a single 300,000 IU oral dose raised serum 25(OH)D from a median of 6.3 ng/mL to 53.3 ng/mL within one week, with no observed toxicity under clinical supervision (Yilmaz, 2023). First, the loading dose approach saturates vitamin D-binding protein and tissue stores more rapidly than incremental daily dosing. Second, severely deficient patients (below 10 ng/mL) may need higher cumulative doses — the Yilmaz study used 600,000 IU total across two consecutive days for this group. Third, serum 25(OH)D should be rechecked 3 months after initiating correction to confirm adequate response and adjust maintenance dosing accordingly. High-dose loading protocols should only be undertaken with medical supervision and baseline blood testing.
How Does D3 Compare to D2 in Absorption?
A 2012 systematic review and meta-analysis in the American Journal of Clinical Nutrition compared D3 and D2 head-to-head across 10 RCTs and concluded that cholecalciferol (D3) is approximately 87% more effective than ergocalciferol (D2) at raising serum 25(OH)D concentrations (Tripkovic et al., 2012). The difference stems from three pharmacokinetic factors. First, D3 binds more tightly to vitamin D-binding protein in the bloodstream, extending its circulating half-life compared to D2. Second, D3 suppresses parathyroid hormone (PTH) more effectively than D2 at equivalent doses, which has functional implications for calcium regulation. Third, hepatic 25-hydroxylation — the first activation step — processes D3 more efficiently, producing higher peak levels of 25(OH)D per unit dose. D2 remains a viable option for strict vegans, as it is derived from UV-irradiated fungi, but individuals selecting D2 should consider using approximately double the IU amount to approximate the serum response achieved by D3. Research from the same analysis estimated D3 to be roughly 3.2 times more potent than D2 on a per-dose basis.
What Co-Factors Improve Vitamin D Utilization?
Vitamin D does not operate in isolation — two co-factors are particularly relevant for optimizing its benefits and reducing potential risks.
Vitamin K2 (Menaquinone-7, MK-7): Vitamin D increases intestinal calcium absorption, but vitamin K2 directs that calcium into bones and teeth rather than allowing deposition in soft tissues such as arteries. K2 activates osteocalcin (a bone-building protein) and matrix Gla protein (which inhibits vascular calcification). Supplementing vitamin D without adequate K2 may increase the risk of arterial calcification over time — particularly at higher vitamin D doses. A typical co-supplementation protocol pairs 1,000–2,000 IU vitamin D3 with 100–200 mcg MK-7 daily.
Magnesium: Magnesium is required as a cofactor for the enzymes that convert vitamin D to its active form (both CYP2R1 in the liver and CYP27B1 in the kidneys). Approximately 50% of the US population consumes less than the estimated average requirement for magnesium. Magnesium deficiency can impair vitamin D metabolism even when supplemental vitamin D intake is adequate — meaning that correcting magnesium status may improve vitamin D utilization without increasing vitamin D dose. A supplemental range of 200–400 mg magnesium glycinate or citrate daily supports both vitamin D metabolism and general physiological function.
What Serum Level Should Supplementation Target?
The target serum 25(OH)D level depends on which guideline is followed, as a genuine scientific disagreement exists between two authoritative bodies.
| Guideline Body | Sufficiency Threshold | Optimal Range |
|---|---|---|
| Institute of Medicine (IOM) | ≥20 ng/mL (50 nmol/L) | 20–40 ng/mL |
| Endocrine Society | ≥30 ng/mL (75 nmol/L) | 40–60 ng/mL |
First, the IOM’s 20 ng/mL threshold was designed to meet the calcium absorption and bone health needs of 97.5% of the population — it is a population-level sufficiency floor, not an individual optimization target. Second, the Endocrine Society’s 30 ng/mL threshold reflects evidence that immune function, mood regulation, and musculoskeletal outcomes may benefit from levels above 20 ng/mL. Third, levels above 60 ng/mL have not been associated with additional benefit in controlled trials, and levels above 100 ng/mL carry hypercalcemia risk. For most supplementation purposes, targeting 40–60 ng/mL strikes the balance between the clinical evidence for extra-skeletal benefits and the established safety margin. A serum 25(OH)D blood test (not 1,25-dihydroxyvitamin D) is the correct measurement for assessing vitamin D status.
When Should Vitamin D Be Taken?
Vitamin D is fat-soluble, and absorption depends on the presence of dietary fat in the gastrointestinal tract at the time of ingestion. Taking vitamin D supplements with the largest fat-containing meal of the day maximizes bioavailability. A study measuring serum vitamin D response found that taking vitamin D3 with a fat-containing meal increased absorption by approximately 50% compared to taking it on an empty stomach or with a fat-free meal. First, the fat triggers bile acid secretion, which emulsifies fat-soluble vitamins and facilitates micellar incorporation for intestinal uptake. Second, timing consistency matters more than the specific meal — taking vitamin D with dinner every day is better than sporadically taking it with breakfast. Third, morning versus evening timing does not appear to meaningfully affect serum 25(OH)D levels in controlled comparisons, so the primary consideration is pairing with a fat source rather than time of day. Vitamin D does not cause stimulant-like effects and will not interfere with sleep when taken in the evening.
References
- Ross AC et al. (2011). The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine. Journal of Clinical Endocrinology & Metabolism. PMID: 21118827
- Yilmaz R (2023). Efficacy and safety of single or consecutive double high-dose oral cholecalciferol supplementation. Steroids. PMID: 37673409
- Tripkovic L et al. (2012). Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status. American Journal of Clinical Nutrition. PMID: 22552031